Telbivudine

Details

Files

Generic Name:

Telbivudine

Project Status:

Complete

Therapeutic Area:

Hepatitis B (chronic)

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Brand Name:

Sebivo

Project Line:

Reimbursement Review

Project Number:

SR0088-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Hepatitis B (chronic)

Recommendation Type:

Do not list

Final Recommendation:

September 26, 2007

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : December 4, 2006